SOUTH SAN FRANCISCO, Calif., Oct. 17 MonogramBiosciences, Inc., (Nasdaq: MGRM) announced that it will hold a conferencecall on Wednesday, October 24, 2007 at 4:30 p.m. (Eastern Time) to discussthird quarter 2007 financial results. The call will be hosted by Mr. WilliamD. Young, Chairman and CEO of Monogram.
To participate in the live teleconference, please call (877) 548-7912, or(719) 325-4878 for international callers, fifteen minutes before theconference begins. Live audio of the call will be simultaneously broadcastover the Internet and will be available to members of the news media,investors and the general public. Following the live broadcast, a replay ofthe call will also be available at (888) 203-1112 or (719) 457-0820 forinternational callers, through Monday, November 5, 2007. The replay passcodeis 4277521. Access to live and archived audio of the conference call will beavailable by following the appropriate links at www.monogrambio.com andclicking on the Investor Relations link.
The information provided on the teleconference is only accurate at thetime of the conference call, and Monogram will take no responsibility forproviding updated information except as required by law.
About Monogram Biosciences, Inc.
Monogram is advancing individualized medicine by discovering, developingand marketing innovative products to guide and improve treatment of seriousinfectious diseases and cancer. The Company's products are designed to helpdoctors optimize treatment regimens for their patients that lead to betteroutcomes and reduced costs. The Company's technology is also being used bynumerous biopharmaceutical companies to develop new and improved antiviraltherapeutics and vaccines as well as targeted cancer therapeutics. Moreinformation about the Company and its technology can be found on its web siteat www.monogrambio.com.Contacts: Alfred G. Merriweather Jeremiah Hall Chief Financial Officer Feinstein Kean Healthcare Tel: 650 624-4576 Tel: 415 677-2700 amerriweather@ jeremiah.hall@ monogrambio.com fkhealth.com
SOURCE Monogram Biosciences, Inc.